AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$HNGE

Robinson Elliott sold 0 shares of HNGE (indirect holdings)

Robinson Elliott sold 0 indirectly-held shares of Hinge Health, Inc. (HNGE) across 10 trades over 2026-11-09 to 2026-11-11.

Original reporting
SEC EDGAR · Robinson Elliott
Published Nov 13, 2026, 11:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HNGE
Neutral
high confidence
Mentioned
$HNGE
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The filing adds no new material information; investors can safely ignore for trading decisions.

02

Market read

The report is a non‑event; it does not influence HNGE's price or broader market sentiment.

03

What to watch

None; zero‑share transaction carries no hidden significance.

Relevance 2/10Novelty 1/10Timing: same day filing

Background

SEC Form 4 disclosures are primary sources for insider transactions. This filing reports a director selling zero shares, which is a routine administrative entry.

Company-level read

Ticker impact

$HNGENeutralHigh confidence
Context

Form 4 filing shows director Robinson Elliott sold 0 shares of Hinge Health, indicating no change in ownership.

Expected impact

no impact as transaction involved zero shares

Evidence & confidence

The filing reports a zero‑share sale, which does not affect supply‑demand dynamics or investor perception.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

No contrarian angle; the filing conveys no material change.

Key entities

  • Director
    Robinson Elliott

    Director of Hinge Health who filed the Form 4.

  • Company
    Hinge Health, Inc.

    Provider of digital musculoskeletal health solutions, ticker HNGE.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HNGE insider trading history →

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

investing.com
$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.

finance.yahoo.com